ask="N/A"
ask_size="N/A"
average_daily_volume="73513"
bid="21.50"
bid_size="500"
book_value="5.20"
change="-0.31"
change_from_200_day_moving_average="5.84"
change_from_50_day_moving_average="2.32"
change_from_52_week_high="-2.28"
change_From_52_week_low="9.79"
change_in_percent="-1.40%"
close="21.84"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.98"
ebitda="-26.75M"
eps_estimate_current_year="-2.32"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.13"
ex_dividend_date="N/A"
float_shares="8852000"
high="22.41"
high_52_weeks="24.12"
last_trade_date="3/14/2017"
last_trade_price="21.84"
last_trade_size="1725"
last_trade_time="4:00pm"
low="21.34"
low_52_weeks="12.05"
market_capitalization="492.40M"
moving_average_200_day="16.00"
moving_average_50_day="19.52"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="26.75"
open="22.06"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+36.49%"
percent_change_from_50_day_moving_average="+11.88%"
percent_change_from_52_week_high="-9.45%"
percent_change_from_52_week_low="+81.23%"
previous_close="22.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.26"
price_per_sales="101.34"
revenue="4.93M"
shares_outstanding="22546000"
short_ratio="5.61"
stock_exchange="NGM"
symbol="RARX"
volume="73980"
weeks_range_52="12.05 - 24.12"
